Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Abstract

The effective treatment of hypertension is an extremely important consideration in patients with end-stage renal disease (ESRD). Virtually any drug class--with the possible exception of diuretics--can be used to treat hypertension in the patient with ESRD. Despite there being such a wide range of treatment options, drugs which interrupt the renin… (More)

Topics

  • Presentations referencing similar topics